Covert macrovascular disease and early outcome after ischemic cerebrovascular events - Takeaways - MDSpire

Covert macrovascular disease and early outcome after ischemic cerebrovascular events

  • By

  • Priyanka Boettger

  • Linda Vollmann

  • Jamschid Sedighi

  • Hassan Hassan

  • Heinz Frederik Noll

  • Pascal Bauer

  • Tobias Braun

  • Michael Buerke

  • Heidrun Kraemer-Best

  • Martin Juenemann

  • Omar Alhaj Omar

  • Samuel Sossalla

  • June 8, 2026

  • 0 min

Share

  • 1

    Covert macrovascular disease (CMVD) includes non-stenotic plaques and structural vascular abnormalities not classified as culprit lesions.

  • 2

    CMVD may influence cerebral perfusion and functional recovery after ischemic stroke, challenging traditional stroke taxonomy.

  • 3

    The study aimed to assess the prevalence and prognostic relevance of CMVD in acute ischemic stroke patients.

  • 4

    Metabolic factors like prediabetes and obesity may exacerbate endothelial dysfunction and vascular inflammation, impacting stroke outcomes.

  • 5

    Understanding CMVD's role could enhance prognostication and inform secondary prevention strategies beyond stenotic disease.

Original Source(s)

Covert macrovascular disease and early outcome after ischemic cerebrovascular events

  • by Priyanka Boettger, Linda Vollmann, Jamschid Sedighi, Hassan Hassan, Heinz Frederik Noll, Pascal Bauer, Tobias Braun, Michael Buerke, Heidrun Kraemer-Best, Martin Juenemann, Omar Alhaj Omar, Samuel Sossalla

  • June 8, 2026

Related Content

Early risk stratification and temporal biomarker patterns of trousseau syndrome-related cerebral infarction in lung cancer

Efficacy and safety of acupuncture for post-stroke spasticity: a study protocol for a randomized controlled trial

Differential associations of novel metaflammation indices with incident stroke across traditional Chinese medicine constitutions: a retrospective community-based cohort study of older adults